When binding of 1251-alpha bungarotoxin (1Z51-(rBTX) to hypothalamic membranes is observed over a wide range of concentrations, 3 binding sites can be identified, with estimated equilibrium dissociation constants (Z&s) of 4.1 x 10-l] M, 6.2 x lo-lo M, and 9.1 x lo-' M for high-, low-, and very-low-affinity interactions, respectively. The densities of the high-and lowail'inity sites were similar at 14-21 fmol/mg protein, whereas the very-low-affinity site had approximately 1000 x greater capacity. Association and dissociation kinetics predicted a biphasic binding reaction, with association rate constants of 1.38 x lo* M-I min-' and 7.53 x 10' M-* min-' and dissociation rate constants of 5.23 x 1O-3 min-1 and 1.80 x 1O-3 min-I. The presence of Na+ inhibited the binding of Y-orBTX with a halfmaximally effective concentration of 22 mM. This decrease in binding was associated with the observation of a single binding site with a K,, of 4.3 x lo-lo M and a density of 12.1 fmol/mg protein. In competition binding experiments, aBTX, curare, nicotine, and quinacrine were the most potent competitors. Ace@choline competed with '*%aBTX binding at 2 sites with estimated affinities of 3.6 x 1O-s and 7.4 x 1O-5 M. In the rostra1 hypothalamus, high-affinity binding of 1251-~BTX was localized to the region of the supraoptic nucleus, paraventricular nucleus, suprachiasmatic nucleus, and the nucleus circularis complex. Within magnocellular regions, binding was closely associated with neurophysin-immunoreactive neurons and processes, while in the region of the suprachiasmatic nucleus, the binding was in a perinuclear region surrounding parvocellular neurophysinimmunoreactive neurons.
It is now well recognized that the central nervous system possesses an alpha bungarotoxin-binding protein that is biochemically and pharmacologically similar to the nicotinic acetylcholine receptor (nAChR) of electric eel and muscle (Conti-Tronconi et al., 1985; Dolly and Barnard, 1984; Lowy et al., 1976; Morley, 1981; Oswald and Freeman, 198 1) . The binding of *ZSI-alphabungarotoxin (1251-(rBTX) shows selectivity for ACh-sensitive neurons in vitro (Carbonetto et al., 1978; Chalazonitis et al., 1974; Greene et al., 1973) , is associated with synaptosomes (Salvaterra et al., 1975) and can be localized to the postsynaptic region (Hunt and Schmidt, 1978a; Lentz and Chester, 1977; Marshall, 1981; Smolen, 1983; Vogel et al., 1977) . A reliable pattern of 12SI-aBTX binding has been observed in the brain, the highest overall concentration of sites generally being in the hypothalamus Schmidt, 1978b Marks and Collins, 1982; Morley et al., 1977; Segal et al., 1978) . Various affinities for the binding of lZ51-~BTX to brain membranes have been reported, they range from equilibrium (or kinetic) dissociation constants (KJ as low as 0.4-3 x lO-'O M (Lukas, 1984b, Marks and Collins, 1982; Morley et al., 1977; Salvaterra and Mahler, 1976; Schmidt, 1977; Wang et al., 1978) to intermediate values of l-5 x 1O-9 M (Lukas, 1984a, b; Patrick and Stallcup, 1977a; Salvaterra et al., 1975) and finally to the high values of l-40 x 1O-8 M (Lukas, 1984b; Salvaterra, et al., 1975) . Each of these sites has nAChR-like pharmacology. Given these results, it is not surprising that several investigators have suggested the presence of multiple binding sites for lZSI-~BTX in the central nervous system (Lukas, 1984b; Morley et al., 1983; Schmidt, 1977) .
The above data from binding analyses provide a striking contrast to those experiments in which olBTX has been unable to block the functional activation of the nAChR in spinal cord (Duggan et al., 1976) , sympathetic ganglion (Chou and Lee, 1969) and PC12 cells (Patrick and Stallcup, 1977b) . Efforts to clarify such discrepancies by precipitating the 1251-aBTX-binding protein with monoclonal antibodies to the purified nAChR have yielded mixed results, with some investigators successfully immunoprecipitating the 1251-cuBTX-binding protein (Block and Billiar, 1979; Dolly and Barnard, 1984) while others have been unsuccessful (Patrick and Stallcup, 1977b) . Thus, the precise identity of the cYBTX-binding protein remains questionable. This issue is particularly important for the understanding of the role of the cholinergic network which is thought to control the release of vasopressin or oxytocin. The release of vasopressin is well recognized as being induced by nicotinic cholinergic agonists (Volle and Koelle, 1975) and the system that mediates this response is probably contained within the rostra1 hypothalamus (Sladek, 1983) . Further support for this possibility is provided by the high binding of 12SI-aBTX in the hypothalamus (Marks and Collins, 1982; Morley et al., 1977; Segal et al., 1978) and particularly the supraoptic nucleus (NSO) of the hypothalamus (Hunt and Schmidt, 1978b; Polz-Tejera et al., 1975; Silver and Billiar, 1976) . Electrophysiological evidence indicates that the cells responsive to nicotinic cholinergic agonists may be the same as or similar to the cells that synthesize vasopressin in the NSO of the hypothalamus (Amauld et al., 1983; Barker et al., 197 1; Bioulac et al., 1978; Gahwiler and Dreifuss, 1980; Sakai et al., 1974) . Thus, a nicotinic cholinergic synapse within the NSO may be an important link in the neural mechanisms that control the secretion of vasopressin.
In an effort to evaluate the significance of the binding of lZ51-olBTX in the NSO and the possible presence of nAChRs, we have characterized pharmacologically the binding of lZSI-aBTX in the hypothalamus. A procedure for combining receptor autoradiography and immunocytochemistry on a single free-floating section allowed assessment of the codistribution of neuro-physin-immunoreactive neurons and aBTX binding sites.
Three '251-~BTX binding sites, with Kds ranging from 4.1 x 10-l' to 4.0 x lo-' M, can be discriminated in the brain. The high-affinity sites have nicotinic cholinergic pharmacology, a half-time on the receptor of 2-6 hr, and are sensitive to the cation concentration in the buffer. These high-affinity sites are localized to the region of the NSO, suprachiasmatic nucleus (NSC), paraventricular nucleus (NPV), and nucleus circularis (NC). A high correlation of this binding distribution with neurophysin-immunoreactive magnocellular neurons suggests that these binding sites may have a special relevance for the functional organization of the vasopressin/oxytocin neurosecretory system.
Materials and Methods

Materials
Monoiodinated 12+orBTX was obtained from New England Nuclear at an initial specific activity of 16.5-17.6 rCi/pg (261-279 cpm/fmol). All cholinergic ligands were obtained from Sigma. Normal goat serum was purchased from Antibodies Incorporated. Tetramethylrhodamine isothiocyanate-conjugatedgoat anti-rabbit IgG (TRITC-CAR, lot no. 15967) was purchased from Cappel. The specific RN4 neurophysin antibody : Sokol et al.. 1976 ) was the generous sift of Dr. Alan Robinson, University of Pittsburgh (Grant-AM-16 166). Other materials were of reagent or comparable quality and were from standard sources.
Preparation of membranes for lZ51-(rBTX binding
Male Sprague-Dawley rats were lightly anesthetized with sodium pentobarbital (30 mg/kg). Each rat was then killed by decapitation; the brain was rapidly removed and immersed in ice-cold 0.32 M sucrose. The hypothalamus and brain stem were dissected from the brain on ice . Washed membranes from each region were prepared by homogenizing the tissue in 10 vol of 0.32 M sucrose. The resulting homogenate was centrifuged at 600 x g for 10 min, the pellet discarded, the membrane suspension diluted to a volume of 40 ml with assay buffer (10 mM phosphate buffer, 1 mM EDTA, 0.1 mM phenylethylsulfonyl flouride, 0.02% sodium azide) and centrifuged at 39,000 x g for 20 min. The resulting pellet was resuspended in 40 ml assay buffer and again centrifuged at 39,000 x g. After a total of 3 washes, the tissue was resuspended in assay buffer at a concentration of 100-200 mg/ml and aliquots stored frozen at -80°C. Binding of 1251-(uBTX to the frozen membranes did not differ from that to fresh tissue, and remained stable for at least 1 month.
Characterization of jz51-aBTX binding
Washed membranes were diluted in assay buffer at concentrations ranging from 5 to 50 mg wet wt/ml. A 400 ~1 aliquot of membranes (2-20 mg wet weight) was added to polypropylene tubes containing 6-1000 PM lZSI-~BTX and an appropriate concentration of competing drug or buffer. Final assay volume was 0.5 ml. Tubes were incubated at 22°C for 2.5 hr. The reaction was terminated by adding 10 ml of wash buffer (10 mM phosphate-buffered saline, 0.5% gelatin, pH 7.4), followed by rapid filtration through Schleicher and Schuell no. 30 glass fiber filters. Each filter was washed twice with 100 ml of wash buffer. The dry filters were transferred to 13 x 100 mm tubes and counted in a Tracer gamma counter at an efficiency of 85-90%. This procedure was effective in reducing any nonspecific binding of 'Y-~uBTX to the glass fiber filters to less than 1% of the total counts added at the highest ligand concentrations. These filter blanks were constant within each experiment and were subtracted from the total binding values. Attempts to reduce nonspecific filter binding with other compounds, including serum albumins, poly+-lysine, 0.5 M NaCl, and Prosil (Harden et al., 1983) , were less effective. Nonspecific binding to tissue ranged from 10 to 50% of the total binding, depending on the concentration of lZSI-aBTX in the assay. Both total and nonspecific binding of *251-(rBTX to rat brain membranes were found to be unaffected by pH in the range of 7.0-8. A protocol similar to the above was followed for the binding of 12sI-(YBTX to 50 pm sections of hypothalamus, with the following exceptions: (1) Sections were washed in an excess ofassay buffer and then transferred to a 24-well tissue culture plate containing 12SI-~BTX in a final assay volume of 1 ml. (2) Binding was terminated by transferring the sections through 3 successive 2 min washes in 2 ml of wash buffer and, finally, into a 13 x 100 mm test tube containing 0.5 ml assay buffer. Each section was immediately counted for 1 min in a Tracer gamma counter and then quickly mounted onto a gelatin-chrome alum-coated glass slide and dried in preparation for autoradiography.
Data analysis
Computer analysis of the data from saturation binding and competition binding experiments was accomplished by using either a Gauss-Newton or Marquart nonlinear least-squares regression program that required a minimum of approximately 15 data points per curve. Since highly accurate values are difficult to obtain with nonspecific binding and other potential sources of variability exceeding 10% of the total binding, such values should be considered estimates, particularly for the low-affinity site. Error values for replicate determinations of Kg were &3 1% and ? 102% for the high-and low-affinity sites, respectively. Estimates for both the high-and low-affinity B,,, values were replicated to within f 17%. The saturation binding nonlinear regression was based on the equation,
where B = total ligand specifically bound, L = ligand concentration, Kd, = dissociation constant for the high-affinity site, B-, = density of the high-affinity site, Kdl = dissociation constant for the low-affinity site, and Bm = density of the low-affinity site.
Competition binding nonlinear regression analysis was based on the equation,
where BT = total ligand bound, L = ligand concentration, IC,,, = concentration of drug that inhibits half the high-affinity binding, IC,,, = concentration of drug that inhibits half the low-affinity binding, B,,, = relative density of high-affinity sites, and Bmax2 = relative density of lowaffinity sites. Inhibition constants (K,s) from competition binding experiments were calculated from ZC,, values according to Cheng and Prusoff (1973) :
where IC,, = the concentration of drug that inhibits half the ligand binding, F = the free molar concentration of the ligand, and K,, = the dissociation constant of the ligand. Conditions for competition binding were generally established such that the majority of the ligand binding was to the high-affinity site. Consequently, the high-affinity K,, estimates were used for the calculation of the inhibition constants.
Combined receptor autoradiography and neurophysin immunocytochemistry
Male Sprague-Dawley rats were deeply anesthetized with sodium pentobarbital (60 mg/kg). The chest cavity was opened and the rat was rapidly perfused through the heart with a balanced salt solution (50 ml) followed by 0.5% paraformaldehyde in 50 mM PBS (200 ml, pH 7.4). The brain was removed, blocked, and postfixed overnight at 22°C in the same 0.5% paraformaldehyde solution. Free-floating 50 pm sections were cut on a vibrating microtome and then processed sequentially through the following solutions: (1) 0.01 mM PBS, pH 7.4, 5 min x 2, (2) 0.01 M PBS, 1% normal goat serum, 0.01% sodium azide, 10 min, 
Autoradiography
Slides containing 50 pm sections of hypothalamus were dipped in Kodak NTB-2 emulsion at 45°C in total darkness. The emulsion-coated slides were allowed to dry at room temperature and were then transferred to sealed, desiccated slide boxes, where they were exposed at 4°C for a period of 14-28 d (2000-4000 cpm x d). At the end of the exposure period, the emulsion was developed in Kodak D-19 (1: 1) for 4 min, washed in distilled water for 10 set, and fixed in Kodak fixer for 5 min. Sections were examined unstained or lightly counterstained in Pyronin Y according to the following procedure: (1) Distilled water, 5 dips. (2) Citric acid-sodium phosphate buffer, 20 mM, pH 5.6, 5 dips. (3) 0.2% Pyronin Y in citrate-phosphate buffer, 5 dips. (4) Citrate-phosphate buffer, 5 dips. (5) Distilled water, 5 dips x 2. The sections were then dehydrated in 50, 70, 80, 95, and 100% ethanol (2 min each), cleared in xylene, and coverslipped with Permount. The distribution of silver grains was examined and photographed on a Leitz Orthoplan microscope under both bright-and dark-field illumination.
Results
Binding of low concentrations of lZ51-aBTX to rat brain membranes Binding of '251-aBTX to membranes from rat hypothalamus is linear over a range of at least OS-O.6 mg protein (data not shown). Saturation binding of lZSI-~BTX to hypothalamic membranes is illustrated in Figure 1 . The binding profile is complex, appearing to approach saturation at 4 x lo-lo M 1251-(rBTX and then increasing again. A Scatchard analysis (Fig. 1, bottom) of the data indicated the presence of 2 binding sites. Nonlinear regression analysis (regression lines not shown) identified a highaffinity 12SI-tiBTX binding site, with a Kd of 4.1 x 10-l' M and a maximum density (B,,,,,) of 2 1.1 fmol/mg protein, and a lowaffinity site with a K,, of 6.2 x lo-lo M and a B,,, of 13.9 fmol/ mg protein.
The characteristics of lZ51-(rBTX binding to membranes prepared from brain stem, illustrated in Kinetics of 12'I-~BTX binding The association and dissociation of 1251-aBTX on membranes is illustrated in Figure 3 . Equilibrium is established after approximately 2.5 hr at 22°C and is maintained for at least 18 hr. Dilution of the membranes in 20-fold excess assay buffer containing 1O-8 M (rBTX to halt the association process initiated a relatively rapid decline in the 1251-aBTX bound to the membranes. Analysis of the transformed data (Fig. 4) indicated the presence of a biphasic rate process for both the association and dissociation of 12SI-aBTX. Association rate (k,,) estimates yielded values of 1.38 x lo8 M-I min-I and 7.53 x lo7 M-I min-' for the fast and slow components, respectively. Analysis of the dissociation process yielded rates of 5.23 x 1O-3 min-I and 1.80 x 1O-3 min-' for the fast and slow components, respectively affinity could not be detected using our standard assay conditions, we reduced the specific activity of our 1251-(rBTX to l-2 cpm/fmol by adding unlabeled aBTX. This specific activity was too low to measure the high-affinity binding of lZ51-~BTX. A saturation binding analysis (Fig. 5) confirmed the presence of a very-low-affinity binding site with a Kd of 9.1 x lo-' M and a B,,, of 28.1 pmol/mg protein. Some binding to the low-affinity '251-otBTX binding site was also measured under these conditions, yielding a curvilinear Scatchard plot. 
Efects of Na+ on i251-cuBTX binding
The presence of increasing concentrations of NaCl in the assay buffer progressively inhibited the binding of iZ51-~BTX (Fig. 6 ) with a half-maximally effective concentration of 22 mM. The effect of Na+ on the affinity of rZ51-aBTX for its binding site is illustrated in Figure 7 . In 150 mM Na+, the specific binding of 1251-~uBTX exhibits a saturation binding profile typical of interaction with a single site. Scatchard analysis of the data confirmed the presence of a single site with a Kd of 4.3 x lo-r0 M and a maximum density of 12.1 fmol/mg protein, approximately equal The bindina of each compound in competition with 1*51-aBTX was determined under standard assay conditions at concentrations of 149459 PM 12SI-aBTX. Under such conditions, the number of high-affinity sites occupied, relative to lowaffinity sites, is greater than 5: 1. Inhibition constants (K,) were calculated according to Cheng and Prusoff (1973) . Binding that could not be inhibited by the drugs represented 24 k 9% of total binding. A-E, Bright-field photomicrographs of uncounterstained 50 pm sections illustrating the accumulation of silver grains after incubation in 54-l 11 PM '251-~BTX and processing for autoradiography. Sections were sampled at anterior-posterior coordinates of approximately A6400, A6200, A6 100, A6000, A5800, and A5900 for A-F, respectively, according to the coordinate system of Konig and Klippel(1963) .
Arrow, High density of labeling along the base of the NSO. F, Nonspecific binding of lz51-olBTX. The section is lightly counterstained with Pyronin Y to illustrate the location of the various nuclei. Exposure time, 28 d at 4°C. MagniJication, -38 x . NSO, Supraoptic nucleus; NC, nucleus circularis complex; NSC, suprachiasmatic nucleus; OC, optic chiasm. 26 mM) > Li+ (39 mM) > K+ (47 mM) > Cs+ (54 mM). Concentrations of sucrose up to 150 mM had no effect on the binding of lz51-~BTX.
Pharmacology of i2SI-aBTX binding
The binding of a variety of ligands in competition with YaBTX is summarized in Table 1 . The K, for each compound was calculated according to Cheng and Prusoff (1973) from the concentration at which half-maximal inhibition of binding occurs (ZC,,). The most potent competitor was LuBTX, followed by d-tubocurarine > nicotine, dimethylphenylpiperazinium, and quinacrine > ethopropazine, substance P, butyrlcholine, and acetylcholine > choline, arginine vasopressin, and phenylmethylsulfonyl fluoride. These data must be interpreted cautiously, however, since Hill analyses of the data for ACh, LuBTX, d-tubocurarine, and dimethylphenylpiperazinium reveal slopes of 0.2-0.5, indicating complex binding interactions. The complexity of the competition binding curve for ACh is illustrated in Figure 8 . Hill analysis of the curve (Fig. 8, inset ) yielded a slope of 0.2. A nonlinear regression analysis of the data indicates the presence of two binding sites. The high-affinity binding site (estimated K, = 3.6 x 1O-8 M) accounted for 31.4% of the total binding sites. The low-affinity binding site (estimated K, = 7.4 x 1O-5 M) accounted for 68.6% of the total binding sites. The competition binding of ACh in the presence of 150 mM Na+, where the '251-olBTX is interacting with a single site, reduced the complexity of the ACh binding profile. Inhibition of lz51-aBTX binding in the lo-91 O-6 M range was lost, yielding a steeper curve with a Hill coefficient of 0.53.
Binding of 1z51-orBTX to hypothalamic sections from fixed brain Saturation binding and kinetic analyses of lZSI-aBTX binding to membranes prepared from 0.5% paraformaldehyde-fixed rat brain yielded results similar to those for unfixed membranes. The concentration-dependent accumulation of lZSI-aBTX achieved by free-floating 50 pm sections through the rostra1 hypothalamus of the fixed rat brain is illustrated in Figure 9 . A NELJROPHYSIN Meeker et al. Vol. 6, No. 7, Jul. 1986 Scatchard analysis (Fig. 9, bottom) clearly illustrates the presence of 2 binding components. Dissociation constants of 1.7 x IO-" and 2.0 x 10-l" M were calculated for the high-and lowaffinity interactions, respectively. The density of the high-affinity site was approximately 1.6 fmol/section, while the density of the low-affinity site was approximately 6.1 fmol/section.
Distribution of high-ajinity 12'I-~BTX binding sites in rat hypothalamus The hypothalamic distribution of lZSI-aBTX binding at concentrations that predominantly label the high-affinity site is shown in Figure 10 . The accumulation of 12SI-aBTX is highly selective for the region of the NSO, NSC, and the NC. Weaker labeling occurs in the NPV, and some scattered diffuse labeling in the lateral and anterior dorsal hypothalamus. We observed no consistent, anatomically discrete distribution of 12SI-~BTX that correlated with low-and very-low-affinity binding sites.
The close association of high-affinity lZ51-~BTX binding with neuroendocrine cells is illustrated by the high correlation between the distribution of autoradiographic silver grains and neurophysin-immunoreactive cells on the same section. Examples of the distribution of 1251-~BTX in relation to neurophysinimmunoreactive cells for the NSO, NC, NSC, and NPV are given in Figure 11 . Within the NSO (Fig. 11, A-C) , silver grains were found to be distributed across all neurophysin-immunoreactive cells. The highest density of grains was found to be localized to the ventral dendritic neuropil of the NSO, a region replete with immunofluorescent varicosities thought to be dendrites of the vasopressin and oxytocin magnocellular neurons (Armstrong et al., 1982) . Grain density diminished sharply over the glial cell layer along the basal lamina, in which few or no immunofluorescent varicosities were observed.
The NC (Fig. 11, & ) and magnocellular portions of the posterior lateral, anterior, and periventricular NPV (Fig. 11 , G-I) were similar to the NSO, with silver grains appearing over the immunofluorescent cell bodies and processes. The density of grains in the core of the NC was as high as in the NSO, whereas the density in the NPV was much less. In contrast to the above, the binding of '251-aBTX in the NSC did not overlap with the neurophysin-immunoreactive cell bodies (Fig. 11, G-Z) . The perimeter of the NSC was generally labeled, leaving the immunofluorescent cell bodies in the medial portion of the NSC unlabeled.
Discussion
As many as 3 different sites can be identified for the binding of lZSI-(rBTX to rat hypothalamus and brain stem membranes on the basis of differing affinities and kinetic properties. Each of these sites corresponds to an aBTX binding site that has been described previously. Saturation binding experiments by Schmidt (1977) and kinetically determined affinities by Lukas (1984b) have yielded Kds of 4-5 x 10-l' M. Salvaterra et al. (1975) and Lukas (1984b) have observed both high-and low-affinity binding sites in the same preparations with Kds of 0.9-5 x 1O-9 M and l-40 x 1O-8 M, respectively, for the high-and low-affinity sites. Other investigators have reported single affinities of l-5 x 1O-9 M for the binding of lz51-~BTX to brain membranes (Lukas, 1984a; Patrick and Stallcup, 1977b; Salvaterra et al., 1975) . Failure to observe more than one binding site can often be attributed to the use of a restricted range of ligand concentrations or to the cation concentration of the binding buffer.
The significance of each type of i251-aBTX binding remains to be determined, but a substantial body of existing data indicates that lz51-aBTX binds with high affinity to a nicotinic cholinergic receptor-like polypeptide in rat brain. This binding is (1) on synaptosomes (Salvaterra et al., 1975) , (2) associated with a protein with hydrodynamic properties and an isoelectric point similar to Torpedo nicotinic receptors (Lowy et al., 1976; Salvaterra and Mahler, 1976) , (3) localized to the postsynaptic membrane (Hunt and Schmidt, 1978a; Lentz and Chester, 1977; Smolen, 1983; Vogel et al., 1977) , (4) nonuniformly distributed in brain Schmidt, 1978b, Marks and Collins, 1982; Morley et al., 1977; Polz-Tejera et al., 1975; Segal et al., 1978; Silver and Billiar, 1976) , and (5) able, in some cases, to be immunoprecipitated by antibodies to the purified nicotinic cholinergic receptor (Block and Billiar, 1979; Conti-Tronconi et al., 1985; Dolly and Barnard, 1984) .
The binding of various drugs in competition with lz51-aBTX is also consistent with that expected for a nicotinic cholinergic receptor, with d-tubocurarine, nicotine, and dimethylphenylpiperazinium inhibiting the binding of 1251-~BTX at relatively low concentrations. Each compound interacted with both the high-and low-affinity '251-(uBTX binding sites. Inhibition of binding by ACh was particularly complex, as is illustrated by the heterogeneity of the competition curve. The shallow slope of the competition curve indicates that ACh recognizes 2 binding sites, with estimated affinities of 3.6 x 1O-8 M and 7.4 x 1O-5 M. Computer analysis of the ACh competition binding curve indicated that 3 1.4% of the total binding sites corresponded to high-affinity ACh binding, whereas 68.6% of the binding sites were of low affinity. This distribution of high-and lowaffinity sites is similar to what would be predicted from the concentration of lZ51-~BTX (5 17 PM) used in the assay, given the K,, values obtained from the Scatchard analysis. Competition binding experiments in the presence of 150 mM Na+, where only a single '251-aBTX binding site can be discriminated, eliminated the high-affinity ACh interaction but increased the Hill slope only to a value of 0.53, suggesting that ACh was still interacting at 2 sites. Thus, it would appear that the high-affinity ACh binding may have corresponded to a low-affinity 12SI-aBTX binding site and that the heterogeneous ACh binding reflected in the competition curve was not simply a function of the complexity of the i251-~BTX interaction.
Evidence indicating that several polypeptides in the CNS bind cholinergic ligands and that substantial variation may exist between different types of tissue has been accumulating over the past several years. For example, multiple nicotinic cholinergiclike binding sites have been reported for 3H-nicotine (Roman0 and Goldstein, 1980), 3H-dihydro-P-erythrodine (Williams and Robinson, 1984) , as well as '251-aBTX (Lukas, 1984b; Salvaterra et al., 1975; Yazulla and Schmidt, 1977) . Only a single binding site has been reported for 3H-ACh (Schwartz et al., 1982) , but a site with a Kd greater than 1 O-* M could not have been measured because of high nonspecific binding. More biochemical characterization is needed to clearly evaluate the significance and interrelationships of each of these binding sites. Our data, indicating that lZ51-aBTX can bind specifically to 3 different binding sites in rat brain, compare favorably with the observation of Betz et al. (1982) that '251-~BTX binds to 3 different polypeptides isolated from chick retina. Only 1 of these polypeptides was similar in size to purified nAChR. The protein from rat brain that binds lZ51-~BTX can be 75% precipitated by antibodies to muscle nAChR, but not by antibodies to Torpedo nAChR (Mills and Wonnacott, 1984) . Recently, Conti-Tronconi et al. (1985) have demonstrated an ACh receptor from chick brain that is homologous, but not identical, to the muscle nicotinic ACh receptor.
The binding of 1251-aBTX to rat brain membranes is highly sensitive to the Na+ concentration in the buffer. The sharp decline in binding as the buffer Na+ concentration increases appears to be due to a decrease in the affinity of the 1251-aBTX for the high-affinity binding site, and possibly to a loss of the lowaffinity binding site. All monovalent cations decrease the binding of 1251-olBTX, indicating a general lack of cation specificity. The order of potency of the various cations does not predict a simple interaction of aBTX with the Na+ channel. The significance of this cation sensitivity remains to be determined.
To better understand the relationship between the vasopressin/oxytocin neuroendocrine system and its stimulation by putative nicotinic cholinergic input, we have assessed the binding of 1251-~BTX to free-floating sections of 0.5% paraformaldehyde-fixed hypothalamus under conditions that allow doublelabeling with an immunocytochemical probe. With this approach, it is clear that high-affinity binding sites for 1251-(uBTX are concentrated in the region of the NSO, NC, NPV, and NSC. Of these regions, the NSO contains the most striking concentration of lZ51-aBTX binding sites. The binding overlaps greatly with the localization of neurophysin-immunofluorescent perikarya, particularly the ventral neuropil, which contains a dense network of dendrite-like processes extending from the vasopressin and oxytocin neurons of the NSO (Armstrong et al., 1982; Yulis et al., 1984) . These processes form a bundle that is sandwiched between the magnocellular perikarya of the NSO and a thin glial cushion that, along with the basal lamina, makes up the ventral surface of the brain. A high density of synaptic contacts (Armstrong et al., 1982) and catecholamine varicosities (McNeil1 and Sladek, 1980) within the ventral neuropil, as compared to that in the NSO (Leranth et al., 1975) , suggests that much of the synaptic input to the cells of the NSO is mediated by contacts within the ventral neuropil. Many of the presynaptic terminals found contacting these processes contain round, clear vesicles similar to cholinergic endings (Yulis et al., 1984) .
A similar pattern of binding was apparent in the NC and NPV. The small groups of magnocellular neurons making up the NC contain either vasopressin or oxytocin (Rhodes et al., 198 1) and are organized in a circular fashion around blood vessels, with bundles of immunoreactive fibers following the vessel in the core of the nucleus. The present data helped to establish the NC as a possible primary target for cholinergic control of vasopressin/oxytocin secretion. The magnocellular neurons of the NPV also bound 12SI-aBTX but appeared to have a lower density of sites than those of the NSO or NC. Again, though, binding was associated exclusively with the regions of the NPV that contained neurophysin-immunoreactive cell bodies.
The parvocellular vasopressin-containing cells of the NSC were a contrast to the magnocellular neurons of the NSO, NC and NPV. Although a relatively high concentration of binding sites was present in the region surrounding the NSC, little or no overlap with neurophysin-immunoreactive cell bodies was observed. Vasopressin fibers projecting dorsally from the NSC (Sofroniew and Weindl, 1978) or dendrites extending laterally from the ventral NSC (Stephan et al., 198 1; van den Pol, 1980) could be a potential target for cholinergic input. Assessment of this possibility will require closer examination of the 1251-aBTX binding site within this region. Some support for an interaction of a putative nicotinic cholinergic receptor with the NSC has been provided by the observation that cuBTX, applied locally to the region of the NSC, blocks the effects of light or cholinergic stimulation on serotonin-N-acetyltransferase activity in the pineal (Zatz and Brownstein, 198 1) .
Within the rostra1 hypothalamus, the magnocellular, neuroendocrine cells of the NSO, NC, and NPV are associated with the highest density of high-affinity lz51-~BTX binding sites. The reason for this association is presently unknown but may reflect input from a nicotinic cholinergic system that is thought to control the release of vasopressin. Our findings supplement the recent work of Mason (1985) which illustrates staining of the NSO with a monoclonal antibody to the alpha subunit of the nicotinic cholinergic receptor of electric eel. The hypothalamic neuroendocrine system may be a model system for the clarification of the significance of the cvBTX binding site in brain, as well as for the understanding of the control of vasopressin secretion.
